/
/
/

Torrent Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹4921 Cr₹4197 Cr₹3303 Cr₹3302 Cr₹3178 Cr₹2959 Cr₹2809 Cr₹2889 Cr₹2859 Cr₹2745 Cr₹2732 Cr₹2660 Cr₹2591 Cr₹2491 Cr₹2491 Cr₹2291 Cr₹2347 Cr₹2131 Cr₹2108 Cr₹2137 Cr₹2134 Cr₹1937 Cr₹1995 Cr₹2017 Cr₹2056 Cr₹1946 Cr₹1966 Cr₹2005 Cr₹2022 Cr₹1856 Cr₹2051 Cr₹1894 Cr₹1872 Cr₹1708 Cr₹1463 Cr₹1417 Cr₹1362 Cr₹1434 Cr₹1443 Cr₹1429 Cr₹1551 Cr₹1503 Cr₹1542 Cr₹1693 Cr₹1947 Cr₹1154 Cr₹1168 Cr₹1217 Cr₹1114 Cr₹1225 Cr₹1015 Cr₹972 Cr₹972 Cr₹871 Cr₹797 Cr₹777 Cr
-₹12 Cr-₹17 Cr-₹13 Cr-₹27 Cr-₹37 Cr-₹18 Cr₹33 Cr-₹16 Cr₹24 Cr₹31 Cr-₹33 Cr₹26 Cr₹34 Cr₹9 Cr-₹10 Cr₹16 Cr₹30 Cr₹56 Cr₹48 Cr₹51 Cr₹40 Cr₹39 Cr₹8 Cr₹6 Cr₹4 Cr₹15 Cr₹53 Cr₹34 Cr₹20 Cr₹17 Cr₹3 Cr₹10 Cr₹27 Cr₹42 Cr₹74 Cr₹78 Cr₹105 Cr₹104 Cr₹50 Cr₹43 Cr₹26 Cr₹24 Cr₹55 Cr₹71 Cr₹75 Cr₹100 Cr₹65 Cr₹72 Cr₹49 Cr₹10 Cr₹10 Cr₹10 Cr₹8 Cr₹8 Cr₹9 Cr₹12 Cr
₹4909 Cr₹4180 Cr₹3290 Cr₹3275 Cr₹3141 Cr₹2941 Cr₹2842 Cr₹2873 Cr₹2883 Cr₹2776 Cr₹2699 Cr₹2686 Cr₹2625 Cr₹2500 Cr₹2481 Cr₹2307 Cr₹2377 Cr₹2187 Cr₹2156 Cr₹2188 Cr₹2174 Cr₹1976 Cr₹2003 Cr₹2023 Cr₹2060 Cr₹1961 Cr₹2019 Cr₹2039 Cr₹2042 Cr₹1873 Cr₹2054 Cr₹1904 Cr₹1899 Cr₹1750 Cr₹1537 Cr₹1495 Cr₹1467 Cr₹1538 Cr₹1493 Cr₹1472 Cr₹1577 Cr₹1527 Cr₹1597 Cr₹1764 Cr₹2022 Cr₹1254 Cr₹1233 Cr₹1289 Cr₹1163 Cr₹1235 Cr₹1025 Cr₹982 Cr₹980 Cr₹879 Cr₹806 Cr₹789 Cr
₹3850 Cr₹3349 Cr₹2421 Cr₹2423 Cr₹2347 Cr₹2196 Cr₹2094 Cr₹2148 Cr₹2152 Cr₹2065 Cr₹2076 Cr₹2036 Cr₹1991 Cr₹1960 Cr₹1960 Cr₹1775 Cr₹1790 Cr₹1732 Cr₹1737 Cr₹1645 Cr₹1622 Cr₹1520 Cr₹1555 Cr₹1547 Cr₹1556 Cr₹1566 Cr₹1589 Cr₹1627 Cr₹1641 Cr₹1543 Cr₹1646 Cr₹1573 Cr₹1545 Cr₹1495 Cr₹1198 Cr₹1172 Cr₹1145 Cr₹1236 Cr₹1200 Cr₹1168 Cr₹1182 Cr₹1079 Cr₹983 Cr₹1035 Cr₹1092 Cr₹1052 Cr₹982 Cr₹1000 Cr₹790 Cr₹898 Cr₹821 Cr₹815 Cr₹785 Cr₹673 Cr₹656 Cr₹643 Cr
₹1652 Cr₹1339 Cr₹1075 Cr₹1056 Cr₹995 Cr₹946 Cr₹947 Cr₹923 Cr₹928 Cr₹914 Cr₹836 Cr₹851 Cr₹825 Cr₹736 Cr₹714 Cr₹695 Cr₹742 Cr₹617 Cr₹586 Cr₹711 Cr₹717 Cr₹621 Cr₹615 Cr₹641 Cr₹665 Cr₹563 Cr₹593 Cr₹575 Cr₹561 Cr₹490 Cr₹564 Cr₹483 Cr₹504 Cr₹406 Cr₹433 Cr₹407 Cr₹402 Cr₹399 Cr₹366 Cr₹373 Cr₹463 Cr₹511 Cr₹673 Cr₹788 Cr₹987 Cr₹262 Cr₹305 Cr₹345 Cr₹394 Cr₹360 Cr₹225 Cr₹189 Cr₹216 Cr₹228 Cr₹171 Cr₹166 Cr
₹305 Cr₹236 Cr₹45 Cr₹48 Cr₹56 Cr₹56 Cr₹57 Cr₹64 Cr₹75 Cr₹80 Cr₹80 Cr₹91 Cr₹103 Cr₹107 Cr₹102 Cr₹69 Cr₹55 Cr₹57 Cr₹62 Cr₹71 Cr₹68 Cr₹73 Cr₹91 Cr₹92 Cr₹102 Cr₹102 Cr₹111 Cr₹116 Cr₹122 Cr₹123 Cr₹133 Cr₹126 Cr₹122 Cr₹121 Cr₹80 Cr₹51 Cr₹56 Cr₹58 Cr₹48 Cr₹51 Cr₹49 Cr₹38 Cr₹43 Cr₹48 Cr₹55 Cr₹47 Cr₹50 Cr₹54 Cr₹24 Cr₹20 Cr₹16 Cr₹15 Cr₹8 Cr₹10 Cr₹7 Cr₹7 Cr
₹733 Cr₹529 Cr₹814 Cr₹791 Cr₹738 Cr₹665 Cr₹691 Cr₹661 Cr₹656 Cr₹631 Cr₹631 Cr₹559 Cr₹531 Cr₹433 Cr₹419 Cr₹463 Cr₹532 Cr-₹87 Cr₹357 Cr₹472 Cr₹484 Cr₹383 Cr₹357 Cr₹384 Cr₹402 Cr₹293 Cr₹319 Cr₹296 Cr₹279 Cr-₹150 Cr₹275 Cr₹205 Cr₹232 Cr₹134 Cr₹259 Cr₹272 Cr₹266 Cr₹244 Cr₹245 Cr₹253 Cr₹346 Cr₹410 Cr₹377 Cr₹681 Cr₹875 Cr₹155 Cr₹201 Cr₹235 Cr₹349 Cr₹317 Cr₹188 Cr₹152 Cr₹187 Cr₹159 Cr₹143 Cr₹139 Cr
₹566 Cr₹364 Cr₹635 Cr₹591 Cr₹548 Cr₹498 Cr₹503 Cr₹453 Cr₹457 Cr₹449 Cr₹443 Cr₹386 Cr₹378 Cr₹287 Cr₹292 Cr₹312 Cr₹354 Cr-₹118 Cr₹249 Cr₹316 Cr₹330 Cr₹324 Cr₹297 Cr₹310 Cr₹321 Cr₹314 Cr₹251 Cr₹244 Cr₹216 Cr-₹152 Cr₹246 Cr₹179 Cr₹163 Cr₹228 Cr₹58 Cr₹204 Cr₹188 Cr₹206 Cr₹229 Cr₹207 Cr₹292 Cr₹284 Cr₹290 Cr₹509 Cr₹650 Cr₹130 Cr₹167 Cr₹198 Cr₹256 Cr₹244 Cr₹158 Cr₹113 Cr₹149 Cr₹111 Cr₹112 Cr₹108 Cr

Share Price Live Stats

Open (₹)4,930.00
Volume (₹)59,518.00
High (₹)4,941.00
Upper Circuit5,396.00
Low (₹)4,885.00
Lower Circuit4,415.00
Prev Close4,905.50
52W High (₹)5,250.00
Price4,889.00
52W Low (₹)3,480.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)187320.00 Cr
Div. Yield (%)0.77
PE Ratio85.89
Debt to Equity1.76
Price to Book17.03
Book Value247.84
EPS (TTM)57.34
Face Value5.00
ROE (%)26.76

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1903-17 (-0.89%)
1902
1984.80
4,56,833Cr
9189-50 (-0.54%)
9087
9467
2,45,426Cr
4889-161 (-3.19%)
4885
5066
1,87,320Cr
1132.2-58.8 (-4.94%)
1125.10
1187
1,13,217Cr
1390.5-33 (-2.32%)
1376.70
1426.10
1,12,212Cr
1853.9-84.6 (-4.36%)
1811.70
1949
1,01,155Cr
2125.9-45.6 (-2.10%)
2118.10
2192
97,626Cr
2350.2-32.7 (-1.37%)
2341.20
2419.20
96,859Cr
1164.3-13.7 (-1.16%)
1154.40
1179.90
96,406Cr
1653.8+8.5 (0.52%)
1622.60
1717
93,614Cr

Key Highlights of Torrent Pharmaceuticals Ltd’s P&L

In 2026-03-31, Torrent Pharmaceuticals Ltd reported total revenue of ₹14071.41Cr, compared with ₹11556.01Cr in 2025-03-31, reflecting Torrent Pharmaceuticals Ltd turnover.

Depreciation was ₹1118.87Cr and finance costs were ₹385.07Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹2872.19Cr in 2026-03-31 as compared to ₹2672.81Cr in 2025-03-31.

Net Profit (PAT) was ₹2163.37Cr in 2026-03-31 compared with ₹1911.25Cr in 2025-03-31.

Earnings per share (EPS) were ₹63.92 in 2026-03-31, compared with ₹56.47 in 2025-03-31.